Andreas Halvorsen - Viking Global Investors
Holding/activity history for Inhibrx (INBX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 1,437,705 | 0.27 | $67.23 | $96,656,907 | SEC | ||
| 2025 Q4 | 1,437,705 | 0.30 | Reduce 19.58% | 0.03 | $79.00 | $113,578,695 | SEC |
| 2025 Q3 | 1,787,705 | 0.16 | $33.68 | $60,209,904 | SEC | ||
| 2025 Q2 | 1,787,705 | 0.07 | $14.27 | $25,510,550 | SEC | ||
| 2025 Q1 | 1,787,705 | 0.08 | $13.99 | $25,009,993 | SEC | ||
| 2024 Q4 | 1,787,705 | 0.09 | $15.40 | $27,530,657 | SEC | ||
| 2024 Q3 | 1,787,705 | 0.10 | $15.66 | $27,995,460 | SEC | ||
| 2024 Q2 | 1,787,705 | 0.10 | Reduce 75.00% | 0.70 | $14.17 | $25,331,780 | SEC |
| 2024 Q1 | 7,150,826 | 0.93 | $34.96 | $249,992,877 | SEC | ||
| 2023 Q4 | 7,150,826 | 1.00 | $38.00 | $271,731,388 | SEC | ||
| 2023 Q3 | 7,150,826 | 0.53 | Add 7.71% | 0.04 | $18.35 | $131,217,657 | SEC |
| 2023 Q2 | 6,639,199 | 0.71 | $25.96 | $172,353,606 | SEC | ||
| 2023 Q1 | 6,639,199 | 0.59 | $18.87 | $125,281,685 | SEC | ||
| 2022 Q4 | 6,639,199 | 0.82 | Add 25.13% | 0.16 | $24.64 | $163,589,863 | SEC |
| 2022 Q3 | 5,305,866 | 0.44 | $17.95 | $95,240,000 | SEC | ||
| 2022 Q2 | 5,305,866 | 0.28 | $11.35 | $60,222,000 | SEC | ||
| 2022 Q1 | 5,305,866 | 0.48 | $22.28 | $118,215,000 | SEC | ||
| 2021 Q4 | 5,305,866 | 0.67 | $43.67 | $231,707,000 | SEC | ||
| 2021 Q3 | 5,305,866 | 0.49 | $33.31 | $176,738,000 | SEC | ||
| 2021 Q2 | 5,305,866 | 0.44 | $27.52 | $146,017,000 | SEC | ||
| 2021 Q1 | 5,305,866 | 0.32 | $20.07 | $106,489,000 | SEC | ||
| 2020 Q4 | 5,305,866 | 0.48 | $32.97 | $174,934,000 | SEC | ||
| 2020 Q3 | 5,305,866 | 0.35 | Buy | 0.35 | $18.00 | $95,506,000 | SEC |